Hong Kong stock kangxinuo biological continued to rise, up more than 10% to HK $79.45.

Beyond Capital: Why Europe Needs Industrial Partners, Not Just Investors

Europe’s reindustrialization is creating new opportunities for Chinese companies. However, the winners will not necessarily be those seeking quick acquisitions or rapid market access. The real opportunities belong to companies capable of embedding themselves into Europe’s industrial ecosystem and supporting the long-term transformation of local industries.

Shanghai Electric Wins Malaysia’s 500MW Samalaju Project, Advancing Gas Turbine Exports

Shanghai Electric（上海电气）said on September 8 that it had won the bid for Unit 3 of the Samalaju combined-cycle gas power project in Sarawak, Malaysia. The 500MW-class unit will use a gas turbine manufactured by the Chinese group, which described the award as paving the way for its first overseas application of such equipment.

Zhipu AI’s H1 Revenue Jumps Nearly 400% as API Business Takes 86.5% of Sales

Zhipu AI（智谱）reported first-half 2026 revenue of CNY 953.9 million, up 399.7% year on year and already above its CNY 724 million full-year revenue for 2025. The result was driven by its cloud-based open platform and API business, which generated CNY 825.2 million, up 2,735.7%, and accounted for 86.5% of total revenue.

CNMPA Approved World's First Inhaled COVID-19 Vaccine Mist

The liquid form of the vaccine is changed into an aerosol using a nebulizer. It can then be inhaled through the mouth using the nebulizer machine. According to CanSino, the vaccine can effectively induce comprehensive immune protection in response to SARS-CoV-2 after just one breath.

China Speed: Two COVID-19 Vaccines Recognized by WHO

As the second blow of the pandemic comes near the sight, China's newly-developed vaccines have been approved by the World Health Organization and available at an affordable price.